This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n8http://linked.opendata.cz/resource/drugbank/drug/DB02805/identifier/pubchem-substance/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02805/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02805/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02805/identifier/pubchem-compound/

Statements

Subject Item
n2:DB02805
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n12:DB02805 n13:DB02805
dcterms:title
1-(3-O-Phosphono-Beta-L-Arabinofuranosyl)Pyrimidine-2,4(1h,3h)-Dione
adms:identifier
n7:DB02805 n8:46505978 n9:UA3 n10:46936464
n4:IUPAC-Name
n5:271B59FF-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B5A05-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B5A04-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B5A01-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B5A02-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B5A03-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B59FD-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B59FB-363D-11E5-9242-09173F13E4C5 n5:271B59FE-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B59FC-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B5A0B-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B5A0C-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B5A06-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B5A07-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B5A09-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B5A08-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B5A0A-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B5A11-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B5A13-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B5A14-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B5A10-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B5A0F-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B5A12-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B5A00-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5A0D-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B5A0E-363D-11E5-9242-09173F13E4C5